96 Publications (Page 2 of 4)
2013
Team-Based Learning in US Colleges and Schools of Pharmacy
Allen, Rondall E⋅Copeland, Jeffrey⋅Franks, Andrea S⋅Karimi, Reza⋅McCollum, Marianne⋅Riese, David J and others
American Association of Colleges of Pharmacy
 
VINEGAROON (ARACHNIDA: THELYPHONIDA: THELYPHONIDAE) TRACKWAY PRODUCTION AND MORPHOLOGY: IMPLICATIONS FOR MEDIA AND MOISTURE CONTROL ON TRACKWAY MORPHOLOGY AND A PROPOSAL FOR A NOVEL SYSTEM OF INTERPRETING ARTHROPOD TRACE FOSSILS
SCHMERGE, JOSHUA⋅RIESE, DAVID and HASIOTIS, STEPHEN
PALAIOS, vol. 28, (no. 2), pp. 128, 2013. | Journal Article
2012
At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.
Foley, John G⋅Nickerson, Nicole⋅Riese, David J⋅Hollenhorst, Peter C⋅Lorch, Gwendolen and Foley, Anne M
Odontology / the Society of the Nippon Dental University, vol. 100, (no. 2), pp. 109-29, 2012/Jul. | Journal Article
 
EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.
Wilson, Kristy J⋅Mill, Christopher⋅Lambert, Sydney⋅Buchman, Jennifer⋅Wilson, Timothy R⋅Hernandez-Gordillo, Victor⋅Gallo, Richard M⋅Ades, Laura M⋅Settleman, Jeffrey E and Riese, David J
Growth factors (Chur, Switzerland), vol. 30, (no. 2), pp. 107-16, 2012/Apr. | Journal Article
 
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
Wilson, Kristy J⋅Mill, Christopher P⋅Gallo, Richard M⋅Cameron, Elizabeth M⋅Van Brocklin, Henry⋅Settleman, Jeffrey E and Riese, David J
The Biochemical journal, vol. 443, (no. 1), pp. 133-44, 2012/Apr/1. | Journal Article
2011
A high throughput, interactive imaging, bright-field wound healing assay
Zordan, Michael D⋅Mill, Christopher P⋅Riese, David J and Leary, James F
Cytometry Part A, vol. 79A, (no. 3), pp. 227-232, 2011. | Journal Article
 
A high throughput, interactive imaging, bright-field wound healing assay.
Zordan, Michael D⋅Mill, Christopher P⋅Riese, David J and Leary, James F
Cytometry. Part A : the journal of the International Society for Analytical Cytology, vol. 79, (no. 3), pp. 227-32, 2011/Mar. | Journal Article
 
ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer.
Mill, Christopher P⋅Zordan, Michael D⋅Rothenberg, S M⋅Settleman, Jeffrey E⋅Leary, James F and Riese, David J
Genes & cancer, vol. 2, (no. 8), pp. 792-804, 2011/Aug. | Journal Article
 
Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
Riese, David J
Expert Opinion on Drug Discovery, vol. 6, (no. 2), pp. 185-193, 2011. | Journal Article
 
Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines
Mill, Christopher P⋅Gettinger, Kathleen L and Riese, David J
Experimental Cell Research, vol. 317, (no. 4), pp. 392-404, Feb 15, 2011. | Journal Article
2010
EGFR signaling in breast cancer: Bad to the bone
Foley, John G⋅Nickerson, Nicole K⋅Nam, Seungyoon⋅Allen, Kah T⋅Gilmore, Jennifer L⋅Nephew, Ken and Riese, David J
Seminars in Cell & Developmental Biology, vol. 21, (no. 9), pp. 951-960, 2010. | Journal Article
2009
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
Frogne, Thomas⋅Benjaminsen, Rikke V⋅Sonne-hansen, Katrine⋅Sørensen, Boe Sandahl⋅Nexø, Ebba⋅Laenkholm, Anne-vibeke⋅Rasmussen, Louise M⋅Riese, David J⋅de Cremoux, Patricia⋅Stenvang, Jan and Lykkesfeldt, Anne E
Breast Cancer Research and Treatment, vol. 114, (no. 2), pp. 263-75, Mar 2009. | Journal Article
 
Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.
Willmarth, Nicole E⋅Baillo, Andrea⋅Dziubinski, Michele L⋅Wilson, Kristy⋅Riese, David J and Ethier, Stephen P
Cellular signalling, vol. 21, (no. 2), pp. 212-9, 2009/Feb. | Journal Article
 
EGFR may couple moderate alcohol consumption to increased breast cancer risk
Mill, Christopher P⋅Chester, Julia A⋅Riese, David J and others
(pp. 31). NIH Public Access
 
EGFR may couple moderate alcohol consumption to increased breast cancer risk
Riese, David⋅Mill, Christopher P⋅Chester, Julia A and Riese, 2nd, David J
Breast Cancer: Targets and Therapy, vol. 1, (no. default), pp. 38, 2009-10-00. | Journal Article
 
Functional selectivity of EGF family peptide growth factors: implications for cancer.
Wilson, Kristy J⋅Gilmore, Jennifer L⋅Foley, John G⋅Lemmon, Mark A and Riese, David J
Pharmacology & therapeutics, vol. 122, (no. 1), pp. 1-8, 2009/Apr. | Journal Article
 
Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase
Coon, Brian G⋅Coon, Brian G⋅Mukherjee, Debarati⋅Mukherjee, Debarati⋅Hanna, Claudia B⋅Hanna, Claudia B⋅Riese, David J⋅Riese, David J⋅Lowe, Martin⋅Lowe, Martin⋅Aguilar, Claudio R and Aguilar, R. Claudio
Human Molecular Genetics, vol. 18, (no. 23), pp. 4491, 20091201. | Journal Article
 
Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
Gilmore, Jennifer L⋅Gonterman, Ryan M⋅Menon, Keshav⋅Lorch, Gwendolen⋅Riese, David J⋅Robling, Alexander and Foley, John G
Molecular cancer research : MCR, vol. 7, (no. 10), pp. 1714-28, 2009/Oct. | Journal Article
2008
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells
Gilmore, Jennifer L⋅Scott, Jeffrey A⋅Bouizar, Zhor⋅Robling, Alexander⋅Pitfield, Sarah E⋅Riese, David J and Foley, John G
Breast Cancer Research and Treatment, vol. 110, (no. 3), pp. 493-505, Aug 2008. | Journal Article
 
Comparison of the enantiomers of (±)-doxanthrine, a high efficacy full dopamine D1 receptor agonist, and a reversal of enantioselectivity at D1 versus alpha2C adrenergic receptors
Przybyla, Julie⋅Przybyla, Julie A⋅Cueva, Juan⋅Cueva, Juan P⋅Chemel, Benjamin⋅Chemel, Benjamin R⋅Hsu, KJoseph⋅Hsu, K.⋅Riese, David⋅Riese, David J⋅McCorvy, John D⋅McCorvy, John⋅Chester, Julia⋅Chester, Julia A⋅Nichols, David E⋅Nichols, David⋅Watts, Val and Watts, Val J
European Neuropsychopharmacology, vol. 19, (no. 2), pp. 146, 2008. | Journal Article
 
Modeling oncogene addiction using RNA interference
Rothenberg, S M⋅Engelman, Jeffrey A⋅Le, Sheila⋅Riese, David J⋅Haber, Daniel A and Settleman, Jeffrey E
Proceedings of the National Academy of Sciences of the United States of America, vol. 105, (no. 34), Aug 26, 2008. | Journal Article
2007
Inter-conversion of neuregulin2 full and partial agonists for ErbB4
Wilson, KJ⋅Mill, CP⋅Cameron, EM⋅Hobbs, SS⋅Hammer, RP and Riese, David J
Biochemical and Biophysical Research Communications, vol. 364, (no. 2), pp. 351-357, 2007. | Journal Article
 
Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis.
Riese, David J⋅Gallo, Richard M and Settleman, Jeffrey
BioEssays : news and reviews in molecular, cellular and developmental biology, vol. 29, (no. 6), pp. 558-65, 2007/Jun. | Journal Article
 
Oncogenic Activity of Epidermal Growth Factor Receptor Kinase Mutant Alleles Is Enhanced by the T790M Drug Resistance Mutation
Godin-Heymann, Nadia⋅Bryant, Ianthe⋅Rivera, Miguel N⋅Ulkus, Lindsey⋅Bell, Daphne W⋅Riese, David J⋅Settleman, Jeffrey E and Haber, Daniel A
Cancer Research, vol. 67, (no. 15), pp. 7319-7326, 2007. | Journal Article
 
The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056
Gallo, R.M. and Riese II, D.J.
(pp. 329-333)